John Kurek

John is the Biotechnology Investment Manager at Uniseed, Australia’s longest running venture fund, operating at the Universities of Melbourne, Queensland, Sydney, New South Wales and the CSIRO. In this role John is responsible for identifying new investment opportunities, and also covers Uniseed’s overall biotechnology and life sciences portfolio. John brings 20+ years of industry experience as a Biotechnology Manager with a focus on the strategic design and implementation of drug development programs. John’s previous roles have included Pharmaceutical Development Manager at BioDiem Ltd., managing the preclinical, clinical and regulatory aspects of BioDiem’s drug development programs, and Preclinical Development Manager at Amrad Corporation Ltd., where he was responsible for the management of preclinical drug development projects. His experience extends from drug discovery to the clinical phase of drug development. John has a PhD in Neuroscience and a Post Graduate Diploma in Drug Evaluation and Pharmaceutical Science, both from the University of Melbourne and is a Graduate of the Australian Institute of Company Directors.